Ignite Creation Date:
2024-05-06 @ 8:08 PM
Last Modification Date:
2024-10-26 @ 3:21 PM
Study NCT ID:
NCT06266715
Status:
RECRUITING
Last Update Posted:
2024-03-19
First Post:
2024-01-31
Brief Title:
Improvement of Depression With Use of ATP
Sponsor:
Nanfang Hospital Southern Medical University
Organization:
Nanfang Hospital Southern Medical University
Study Overview
Official Title:
A Double-blind Randomized Controlled Trial of Adenosine Disodium Triphosphate in Improving Moderate to Severe Depressions
Status:
RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This clinical study is a randomized double-blind placebo-controlled trial with an intervention period of 4 weeks Participants will be patients with moderate to severe depression who meet the inclusion criteria during the screening period After recruitment written informed consent form will be signed and the baseline evaluation will be done then the treatment period follows The subjects will be randomly assigned to a control group escitalopram plus normal salineNA and an ATP group escitalopram plus adenosine disodium triphosphateATP in a 11 ratio for treatment with a total number of 120 recruited patients Assessment will be carried out as an analysis of changes in Hamilton Depression ScaleHAMD-24 cognitive function test brain functional network inflammatory markers and other indicators in the first second and fourth week of intervention which will evaluate the effectiveness of ATP in improving moderate to severe depression preliminarily
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None